Vimarsana
Biggest News Aggregation in the World

Page 18 - Preventive Services Task Force News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preventive Services Task Force. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preventive Services Task Force Today - Breaking & Trending Today

Mammograms should start at 40, says US task force - Vimarsana News

Mammograms should start at 40, says US task force

Breast cancer is the second most common cancer and the second most common cause of cancer death for women in the United States

Mammograms should start at 40, says US task force - Vimarsana News

Mammograms should start at 40, says US task force

Breast cancer is the second most common cancer in the US

Preventive Care In A Post-Braidwood World: Agencies Release Guidance On Preventive Services Coverage Requirements - Health & Safety - Vimarsana News

Preventive Care In A Post-Braidwood World: Agencies Release Guidance On Preventive Services Coverage Requirements - Health & Safety

The Departments of Labor, Treasury, and Health and Human Services (the "Departments") recently released guidance for group health plans on required preventive services coverage.

Source: mondaq.com
Nicholas Bagley Speaks About Braidwood v Becerra Background, Implications - Vimarsana News

Nicholas Bagley Speaks About Braidwood v Becerra Background, Implications

Nicholas Bagley, JD, of Michigan Law, University of Michigan, explained what the Braidwood v Becerra court case was about and how the ruling affected preventive care across the country.

Source: ajmc.com
Frontiers | Mode of presentation and performance of serology assays for diagnosing celiac disease: A single-center study in the United Arab Emirates - Vimarsana News

Frontiers | Mode of presentation and performance of serology assays for diagnosing celiac disease: A single-center study in the United Arab Emirates

Objective To characterize patients with celiac disease (CD), examines the clinical spectrum of CD, and evaluate the performance of serologic tests used for CD screening, in the United Arab Emirates (UAE). Method Medical charts of patients received at the Digestive Diseases Institute of Cleveland Clinic Abu Dhabi from January 2015 to December 2020 were reviewed. Patients who were screened for four serologic biomarkers (anti-tissue transglutaminase IgA [Anti-tTG-IgA], anti-tissue transglutaminase IgG [Anti-TtG-IgG], anti-deamidated gliadin peptide IgG [Anti-DGP-IgG], and anti-deamidated gliadin ...